Invention Grant
US09126941B2 Treatment of hyperproliferative disorders with diarylhydantoin compounds
有权
用二芳基乙内酰脲化合物治疗过度增殖性疾病
- Patent Title: Treatment of hyperproliferative disorders with diarylhydantoin compounds
- Patent Title (中): 用二芳基乙内酰脲化合物治疗过度增殖性疾病
-
Application No.: US13448964Application Date: 2012-04-17
-
Publication No.: US09126941B2Publication Date: 2015-09-08
- Inventor: Charles L. Sawyers , Michael E. Jung , Charlie D. Chen , Samedy Ouk , Chris Tran , John Wongvipat
- Applicant: Charles L. Sawyers , Michael E. Jung , Charlie D. Chen , Samedy Ouk , Chris Tran , John Wongvipat
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Venable LLP
- Agent Michael A. Gollin; Lars H. Genieser
- Main IPC: A61K31/4166
- IPC: A61K31/4166 ; A61K31/4184 ; C07D233/86 ; C07D235/02 ; C07D233/70 ; C07D233/74 ; C07D471/10
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Public/Granted literature
- US08658681B2 Treatment of hyperproliferative disorders with diarylhydantoin compounds Public/Granted day:2014-02-25
Information query
IPC分类:
